New research shows outcomes are worse for Black patients with acute myeloid leukemia (AML) than white patients who received similar intensive therapy on clinical trials.
- Nearly 3 in 10 Americans Have Insomnia: Survey
- Will Bad Data Undermine Good Tech?
- ‘Smart Inhalers’ May Help Diagnose and Treat Asthma – If Used
- Sexual Dysfunction, Hair Loss Linked With Long COVID
- Diagnosing Kids with Long COVID Can Be Tricky: Experts